Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Neuropathy: later-stage trial registry
8 of 28 indexed Peripheral Neuropathy trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #577 of 28,707 conditions by registered trial count.
28 US clinical trials · 8 currently recruiting · #577 of 28,707 conditions by registered trial count
Peripheral Neuropathy: 28 US clinical trials tracked, 8 recruiting.
Peripheral Neuropathy is the subject of 28 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 3 of these trials.
Enrollment posture brief
Registry condition peripheral-neuropathy
OPEN 8 | RECR 29% | LATE 4 | EARLY 2 | RANK #577 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acne Scars (29% recruiting · 7 trials)
Peripheral Neuropathy lists 8 open slots (29% of 28 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Neuropathy is recruiting below its size-band peers.
8 of 28 indexed trials (28.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Peripheral Neuropathy trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 3 of 28 trials (10.7%). 25 distinct sponsors appear on at least one study for this condition label.
-
Most Peripheral Neuropathy trials plan to enrol fewer than 100 people.
Median target enrolment is 46 among the 28 trials that report a genuine target (sentinel values excluded). 21 of those (75%) plan for fewer than 100 participants.
-
Peripheral Neuropathy research is mostly interventional.
22 interventional and 6 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
28 total, page 1 of 1
DoD AtMS for Posttraumatic Peripheral Neuropathic Pain
Veterans Medical Research Foundation
NCT07301177
Investigational Use of Neuromuscular Ultrasound
National Institute of Neurological Disorders and Stroke (NINDS)
NCT05237973
Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff
University of Iowa
NCT06127264
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
Zabeen Mahuwala, MD
NCT03481283
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
M.D. Anderson Cancer Center
NCT05357469
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
Rush University Medical Center
NCT04909138
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Elpida Therapeutics SPC
NCT06151600
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
Indiana University
NCT07336381
Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)
Nalu Medical
NCT05870124
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies
M.D. Anderson Cancer Center
NCT02221700
Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain
M.D. Anderson Cancer Center
NCT01278225
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NeuraLace Medical
NCT04795635
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
Mayo Clinic
NCT03584022
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
University of South Florida
NCT00369564
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Alliance for Clinical Trials in Oncology
NCT00489411
Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT00264875
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Oncotherapeutics
NCT01697839
StimRouter Registry Clinical Protocol
Bioness
NCT03913689
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Endo Pharmaceuticals
NCT00904202
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Texas Woman's University
NCT01419314
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
Academic and Community Cancer Research United
NCT01637077
Distal Peripheral Neuropathy in Type 2 Diabetes
New York University
NCT05104047
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Washington University School of Medicine
NCT00763087
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
Virginia Commonwealth University
NCT01196442
Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
NCT02364726
Exercise and Oxaliplatin-induced Peripheral Neuropathy
Dartmouth-Hitchcock Medical Center
NCT05916118
Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy
University of Michigan
NCT01480297
Peak Plantar Pressures While Wearing a Carbon Fiber Off Loading Orthoses
Washington University School of Medicine
NCT03618628
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Neuropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Neuropathy page
28 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Peripheral Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Peripheral Neuropathy trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Neuropathy condition card totals 28 registered trials; most-linked intervention pregabalin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.